Highwise Health
U.S.

Prostate Surgery Approach Linked to Lower Survival

A study found that one common robot-assisted prostate surgery technique had worse long-term outcomes than another.

Updated on Oct. 2, 2026 in Men’s Health

Mechanical surgical arms of a robotic system positioned for a medical procedure, reflecting cool clinical light.
A recent clinical trial indicates that the anterior approach for robot-assisted prostatectomy yields better long-term progression-free survival rates than the Retzius-sparing method. AI Illustration. Upload story photo >

Live Poll

Do you trust newer surgical techniques as much as long-established medical procedures?

A clinical trial comparing two robot-assisted prostatectomy approaches found that the Retzius-sparing method resulted in significantly worse progression-free survival compared to the anterior approach. These findings provide long-term follow-up data for men undergoing treatment for low- to intermediate-risk prostate cancer.

Why it matters

Understanding the long-term oncologic outcomes of different surgical techniques is critical for men discussing treatment options with their surgeons. This comparative data highlights the importance of procedure selection in managing prostate cancer recurrence risk.

In a randomized trial of 120 men with low- to intermediate-risk prostate cancer, the Retzius-sparing surgery group showed lower progression-free survival over a median follow-up of 77 months compared to the anterior group.

The players

Vattikuti Urology Institute

A center within the Henry Ford Health System specializing in robotic-assisted urological surgery and advanced prostate cancer care.

The details

The Retzius-sparing robot-assisted radical prostatectomy avoids the traditional anterior approach by accessing the prostate through the space of Retzius. While intended to preserve surrounding tissues, the study reported a 25% positive surgical margin rate, compared to 13% for the anterior method, potentially contributing to the observed differences in long-term biochemical recurrence.

Timeline

  1. Patients underwent surgery between 2015 and 2016.

  2. Survival rates were measured at 5 years.

  3. The median follow-up duration for the study was 77 months.

  4. Survival rates were measured at 10 years.

Health Landscape

This research follows extensive efforts at the Vattikuti Urology Institute to evaluate the evolution of robot-assisted surgical techniques for prostate cancer. It highlights a critical departure from earlier assumptions about the long-term oncologic performance of the Retzius-sparing approach.

Men diagnosed with prostate cancer should discuss the specific surgical technique proposed by their urologist and how it may impact their long-term recurrence risk. It is worth asking your doctor about the comparative oncologic outcomes of different approaches to prostatectomy based on your risk profile.

The takeaway

The choice of surgical technique significantly influences the long-term probability of staying cancer-free for men with low- to intermediate-risk prostate cancer. Ensure you consult with a specialist about the trade-offs between different robotic-assisted approaches for your procedure.

Further reading

For more on navigating prostate cancer care, visit our Men’s Health section.

More information

View the Original clinical trial entry for complete details on the study design.

Source note: This article includes information reported by Oncology Nurse Advisor.

Live Poll

Do you trust newer surgical techniques as much as long-established medical procedures?